Advances in Tumor Genetics

Tumor genes are genes that have the potential to cause cancer. Most normal cells will undergo a programmed form of rapid cell death (apoptosis) when critical functions are altered. Activated tumor genes can cause those cells designated for apoptosis to survive and proliferate instead. Most tumor genes require an additional step, such as mutations in another gene, or environmental factors, such as viral infection, to cause cancer. Fortunately, there are tumor suppressor genes that can regulate cellular differentiation and suppression of proliferation under normal conditions. Mutations in these genes result in unchecked cellular proliferation resulting in tumors with abnormal cell cycles and tumor proliferation. The tumor suppressor genes contribute to cancer by the inactivating of loss of function mutation.

 

In the present book, twelve typical literatures about tumor genetics published on international authoritative journals were selected to introduce the worldwide newest progress, which contains reviews or original researches on medical science, genetics, oncology, etc. We hope this book can demonstrate advances in tumor genetics as well as give references to the researchers, students and other related people.

Components of the Book:
  • Chapter 1
    Tumor Heterogeneity: Next-Generation Sequencing Enhances the View from the Pathologist’s Microscope
  • Chapter 2
    Next Generation Sequencing and Tumor Mutation Profiling: Are We Ready for Routine Use in the Oncology Clinic?
  • Chapter 3
    Age Dependence of Tumor Genetics in Unfavorable Neuroblastoma: ArrayCGH Profiles of 34 Consecutive Cases, Using a Swedish 25-Year Neuroblastoma Cohort for Validation
  • Chapter 4
    A General Framework for Analyzing Tumor Subclonality Using SNP Array and DNA Sequencing Data
  • Chapter 5
    Oncogenes and Tumor Suppressor Genes: Comparative Genomics and Network Perspectives
  • Chapter 6
    Tumor Loci and Their Interactions on Mouse Chromosome 19 That Contribute to Testicular Germ Cell Tumors
  • Chapter 7
    Familial Testicular Germ Cell Tumor: No Associated Syndromic Pattern Identified
  • Chapter 8
    Integrating Genetics and Epigenetics in Breast Cancer: Biological Insights, Experimental, Computational Methods and Therapeutic Potential
  • Chapter 9
    A Joint Analysis of Metabolomics and Genetics of Breast Cancer
  • Chapter 10
    Aberrant PTPRO Methylation in Tumor Tissues as a Potential Biomarker That Predicts Clinical Outcomes in Breast Cancer Patients
  • Chapter 11
    New Concepts in Breast Cancer Genomics and Genetics
  • Chapter 12
    Obtaining Informed Consent for Clinical Tumor and Germline Exome Sequencing Oo Newly Diagnosed Childhood Cancer Patients
Readership: Students, academics, teachers and other people attending or interested in Tumor Genetics
Elaine Mardis
The Genome Institute at Washington University, Washington University, School of Medicine, 4444 Forest Park Blvd, St Louis, USA

Debu Tripathy
University of Southern California, Keck School of Medicine, USC/Norris Comprehensive Cancer Center, 1441 Eastlake Avenue, NTT-3429, Los Angeles, USA

Cihan Cetinkaya
Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden

Bo Li
Program of Bioinformatics, University of Michigan, 5940A Buhl, Box 5618, Ann Arbor, USA

Angabin Matin
Department of Genetics, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

Claudia Cava
Institute of Molecular Bioimaging and Physiology (IBFM), National Research Council (CNR), Milan, Italy

and more...
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top